Skip to content

Public FDA record

Z-1127-03: Premier CMV IgG Elisa Kits, EIA diagnostic test kits, 96 tests per kit, Catalog Numbers: 620096 and 9Z950

Recall record Z-1127-03 for Meridian Bioscience Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1127-03
Company in FDA record
Meridian Bioscience Inc
FDA classification date
Aug 12, 2003
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

The Low Positive Standard kit component is losing potency that may result in false positive test results.

Source facts

Action
The firm notified their customers by telephone and fax on 6/18/2003.
Initiated
2003-06-18
Root cause
Other
Terminated
2004-03-29
Distribution
The kits were shipped to end-users located in CA, UT, NY, MD, KY; and to a foreign distributor in Belgium.
Recall number
Z-1127-03
Recall status
Terminated
CDRH record ID
27792
FDA classified
2003-08-12
Recall event number
26505

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗